P
This precision neurotherapeutics company focuses on developing next-generation therapies for neurodegenerative diseases. They restore protein homeostasis by specifically targeting the proteasome system. The primary goal is to slow, halt, or reverse neurodegeneration associated with Alzheimer's disease and related disorders.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This precision neurotherapeutics company focuses on developing next-generation therapies for neurodegenerative diseases. They restore protein homeostasis by specifically targeting the proteasome system. The primary goal is to slow, halt, or reverse neurodegeneration associated with Alzheimer's disease and related disorders.